Know these first
- L1.8.04: An insurer’s balance sheet
- L4.6.02: Market-consistent valuation and the risk-free curve
- L4.6.03: Technical provisions: the best estimate
- L4.6.04: The risk margin
- L4.6.08: Own funds and the MCR
Math Atoms
By the end you will be able to
- 1Compare the Solvency II best estimate with IFRS 17's PV of future cash flows: the same expected cash flows, different discount rates (Directive Art 77(2); IFRS 17 paras 33–36, B80).
- 2Compare the risk margin with the risk adjustment: a regulated cost of capital at 99.5% against the insurer's own price at its chosen confidence level (Art 77(5); paras 37, 119).
- 3Explain why the CSM is a liability under IFRS 17 and own funds under Solvency II, and measure EPIFP (Delegated Regulation Arts 70(2), 260(2)).
- 4Reconcile RiskAtoms Insurance SE's IFRS 17 liabilities to its Solvency II technical provisions (+€1,855.93m), and bridge its equity to own funds of €9,300m, booked and full.
Why it matters
RiskAtoms Insurance SE publishes two balance sheets for the same contracts on the same day. Its IFRS 17 accounts show equity of €7,000m; its Solvency II report shows own funds of €9,300m. Analysts, supervisors and the board read both. Knowing exactly which pieces differ, and why, is how you tell a real change in the business from a change in the measuring stick.
Module complete